Cabozantinib (C) Exposure-Response (Er) Modeling Of Efficacy And Safety Endpoints As A Function Of Clearance In Patients (Pts) With Renal Cell Carcinoma (Rcc).
JOURNAL OF CLINICAL ONCOLOGY（2018）
关键词
renal cell carcinoma,efficacy,exposure-response
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要